nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

11.08.2023 | Editorial

Strategy planning for turbulent times in nuclear medicine: Time to begin at the beginning?

verfasst von: Rayjanah Allie, Irfan Kayani, Gopinath Gnanasegaran, Sobhan Vinjamuri, Arturo Chiti, Diana Paez, Francesco Giammarile, Ken Herrmann, Jamshed Bomanji

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Strategy planning in nuclear medicine imaging in uncertain times can be a challenging task. In the traditional strategic-planning model, managers attempt to forecast how the imaging landscape will evolve and how competitors will respond. They then define a multi-year plan to position their departments in this envisaged future state. That model worked well when the health landscape and economies were more stable, and the primary factors influencing future growth and expansion were easier to forecast. However, the world and the health landscape are changing so quickly that no service can plan for every eventuality. …

Prakash A, Jha SK, Mohanty R. Scenario planning for service quality: a Monte Carlo simulation study. J Strateg Manag. 2012;5(3):331–52.

Li M, Garrison L Jr, Lee W, Kowal S, Wong W, Veenstra D. A pragmatic guide to assessing real option value for medical technologies. Value Health. 2022; 22:S1098–3015(22)02002–2.

Real Options. A right, but not an obligation, to make a business decision. https://corporatefinanceinstitute.com/resources/derivatives/real-options/. Accessed 7 Jul 2023.

Chang A. Monte Carlo simulations and its use in healthcare. https://ai-med.io/ac-observations/monte-carlosimulations-and-its-use-in-healthcare/. Accessed 7 Jul 2023.

Mankins M, Gottfredson M. Strategy-making in turbulent times: a dynamic new model. Harvard Business Review. 2022. https://hbr.org/2022/09/strategy-making-in-turbulent-times. Accessed 8 Jul 2023.

Bohr A, Memarzadeh K. The rise of artificial intelligence in healthcare applications. Artif Intell Healthcare. 2020:25–60 In Principles of Gender-Specific Medicine Sex and Gender-Specific Biology in the Postgenomic Era, Elsevier Science 2023

Bowman EH, Moskowitz GT. Real options analysis and strategic decision making. Organ Sci. 2001;12(6):772–7.CrossRef

Investopedia team. Beginner’s guide to hedging: definition and example of hedges in finance. 2022. https://www.investopedia.com/. Accessed 7 Jul 2023.

Changing Mindsets to Realize the 2030. How to promote new mindsets and behaviours in public institutions to implement the Sustainable Development Goals. Agenda for Sustainable Development. United Nations Department of Economic and Social Affairs, New York. 2021. Accessed 2 Jul 2023.

10.

Huang HL, Gnanasegaran G, Paez D, Fanti S, Hacker M, Sathekge M, Bom HS, Cerci JJ, Chiti A, Lan X, Herrmann K, Scott AM, Vinjamuri S, Dorbala S, Estrada E, Pellet O, Orellana P, El-Haj N, Giammarile F, Abdel-Wahab M, Bomanji J. Correction to: nuclear medicine services after COVID-19: gearing up back to normality. Eur J Nucl Med Mol Imaging. 2020;47(9):2220 (Erratum for: Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2048-2053).CrossRefPubMedPubMedCentral

11.

Gnanasegaran G, Paez D, Sathekge M, Giammarile F, Fanti S, Chiti A, Bom H, Vinjamuri S, Pascual TN, Bomanji J. Coronavirus (COVID-19) pandemic mediated changing trends in nuclear medicine education and training: time to change and scintillate. Eur J Nucl Med Mol Imaging. 2022;49(2):427–35 (Erratum in: Eur J Nucl Med Mol Imaging. 2022 Dec;50(1):234).CrossRefPubMed

12.

Graham R, Moreira AP, Glaudemans AWJM, Jensen LT, Mihaïlovic J, Nazarenko S, Ozcan Z, Piciu D, Wadsak W, Kunikowska J, Jamar F. 2022 follow-up: impact of the COVID-19 pandemic on nuclear medicine departments in Europe. Eur J Nucl Med Mol Imaging. 2022;49(10):3309–15.CrossRefPubMedPubMedCentral

13.

Allam Z, Bibri SE, Sharpe SA. The rising impacts of the COVID-19 pandemic and the Russia-Ukraine war: energy transition, climate justice, global inequality, and supply chain disruption. Resources. 2022;11:99.CrossRef

14.

Brindis RG, Douglas PS, Hendel RC, American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American Society of Nuclear Cardiology, American Heart Association, et al. ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI): a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group and the American Society of Nuclear Cardiology endorsed by the American Heart Association. J Am Coll Cardiol. 2005;46(8):1587–605.CrossRefPubMed

15.

NICE. Myocardial perfusion scintigraphy for diagnosing and managing angina and myocardial infarction in adults. Technology appraisal guidance [TA73]. 2003. https://www.nice.org.uk/guidance/ta73. Accessed 28 June 2023.

16.

Kamel SI, Intenzo CM, Parker L, Rao V, Levin DC. Recent trends suggest possible inappropriate utilization of myocardial perfusion imaging. J Am Coll Radiol. 2019;16(8):1013–7.CrossRefPubMed

17.

Kumar R. Real options valuation. In: Valuation: theories and concepts. London: Academic Press. In Valuation, Theories and Concepts Academic Press Elsevier Inc 2016, p. 227–236.

18.

Glantz M, Mun J. Strategic real options analysis: managing risk through flexibility. In: Credit engineering for bankers. 2nd ed. Burlington: Academic Press. Elsevier Inc 2011, p. 295–308.

19.

Krenning EP, Kwekkeboom DJ, Bakker WH, et al. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Review Eur J Nucl Med. 1993;20:716–31.CrossRefPubMed

20.

Sartor O, de Bono J, Chi KN, et al. Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer. N Engl J Med. 2021;385(12):1091–103.CrossRefPubMedPubMedCentral

21.

Brownell GL. A history of positron imaging. Presented at the Celebration of the 50th Year of Services to the Massachusetts General Hospital, Cambridge, MA. 1999. https://websites.umich.edu. Accessed 8 Jul 2023.

22.

Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med. 2000;41:1369–79.PubMed

23.

Koh DM, Papanikolaou N, Bick U, et al. Artificial intelligence and machine learning in cancer imaging. Commun Med. 2022;2:133.CrossRefPubMedPubMedCentral

24.

Dixon S. Diagnostic imaging dataset statistical release. By NHS England 17th Feb 2022. Prepared by: Performance Analysis Team Classification. https://www.england.nhs.uk/. Accessed 7 Jul 2023.

Titel: Strategy planning for turbulent times in nuclear medicine: Time to begin at the beginning?
verfasst von: Rayjanah Allie
Irfan Kayani
Gopinath Gnanasegaran
Sobhan Vinjamuri
Arturo Chiti
Diana Paez
Francesco Giammarile
Ken Herrmann
Jamshed Bomanji
Publikationsdatum: 11.08.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 1/2023
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-023-06379-x

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Postoperative [68Ga]Ga-DOTA-TATE PET/CT imaging is prognostic for progression-free survival in meningioma WHO grade 1

The combined evaluation of clinical and biochemical data in management of patients with differentiated thyroid cancer

A look into the future: the role of PSMA beyond prostate cancer

Improved diagnostic accuracy for coronary artery disease detection with quantitative 3D 82Rb PET myocardial perfusion imaging

Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management

Integrated myocardial flow reserve (iMFR) assessment: diffuse atherosclerosis and microvascular dysfunction are more strongly associated with mortality than focally impaired perfusion